At ChristianaCare’s Helen F. Graham Cancer Center & Research Institute, doctors, nurses, scientists and community educators are working together through the Breast Cancer Research Program on cutting-edge studies to discover new and better ways to prevent breast cancer, find it earlier, treat it more effectively and improve both survival rates and quality of life. They are also working to determine why certain populations of women have higher rates of some types of cancer and why outcomes vary among different groups; to identify novel biomarkers that may help us understand who is most likely to get certain cancers or to have a recurrence; and to increase the number of minority women who participate in promising translational research studies
This multidisciplinary team of experts — including leading scientific researchers from the University of Delaware and The Wistar Institute in Philadelphia — translates discoveries newly made in the lab into tests and treatments that improve the lives of women facing breast cancer. From a revolutionary blood screening test with the potential to determine whether cancer is present and likely to spread, to targeted therapies to improve survival outcomes and decrease chemotherapy side effects for women with triple negative breast cancer, to developing new treatments for aggressive breast cancers, the Breast Cancer Research Program is harnessing new technologies and leading-edge advances to advance the science of breast cancer medicine.
The innovative partnerships made possible by ChristianaCare’s Breast Cancer Research Program ensure that cutting-edge diagnostic tools, treatments and services are accessible to every woman in Delaware. We are also building partnerships with community leaders and those with first-hand knowledge of breast cancer through the Community Research Advisory Board to help identify research opportunities that will directly impact the needs of our community and to promote the importance of breast health education and participation in clinical trials.
The Cawley Center for Translational Cancer Research at the Helen F. Graham Cancer Center & Research Institute is seeking applications from Delaware community-based organizations to support research strategies designed to reduce racial disparities in breast cancer in the state. Submissions are due by 5 p.m., December 8, 2023.